About Sure Dividend
Sure Dividend helps you build your high-quality dividend growth portfolio at a tiny fraction of the cost of traditional money management.
Sure Dividend uses The 8 Rules of Dividend Investing to systematically rank high-quality dividend growth stocks. Each of the 8 Rules of Dividend Investing are based on academic research that has historically either increased returns or reduced risk.
These rules combined with a consistent long-term investment philosophy give Sure Dividend investors an edge by lowering investing expenses while investing in great businesses trading at fair or better prices.
Sure Dividend is run by me, Ben Reynolds. I believe investing in great businesses trading at fair or better prices should be inexpensive and easy. The more people that benefit from high-quality dividend growth investing, the fewer people will be left struggling in retirement.
Unlike most newsletters, I respond to questions from my readers personally. My goal is to help as many people as possible benefit from dividend growth investing. Take a moment to visit my site, Sure Dividend. Thanks for taking the time to read my author bio, I hope you’ve found my work useful.
Join InvestorPlace Insights — FREE!
Get actionable advice from our top experts, including the hottest stocks to buy & sell, 401k and retirement tips, market analysis and more!
Bristol-Myers Squibb offers a substantial dividend, but that's far from the only reason that BMY stock is a great investment for 2022.
Despite big gains in 2021, WBA stock still looks undervalued at current levels, with potential annual gains of 7% to 15%.
Fairly valued at worst and more than likely still undervalued, WBA stock offers investors respectable growth and a significant dividend.
Best Stocks For 2021: Walgreens Boots Alliance (WBA) Just Went From Seriously Undervalued to Still Undervalued
Walgreens stock has made serious gains in the first quarter of 2021, but there's still plenty of room for this pharmacy-led retail stock to climb higher.
While its performance during COVID-19 has been lackluster, Walgreens continues to generate great cash flows. But that's not it for WBA stock.